General MedicationsORALStandard
POKONZA
POTASSIUM CHLORIDE
Standard Dose
10MEQ/15ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview POKONZA is listed in Drugs@FDA under application 206814 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient POTASSIUM CHLORIDE Form and strength SOLUTION;ORAL - 10MEQ/15ML Sponsor GENUS LIFESCIENCES Submission history Latest submission status date: 2020-03-05 00:00:00.
Structured Monograph
Clinical summary
Approval overview POKONZA is listed in Drugs@FDA under application 206814 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient POTASSIUM CHLORIDE Form and strength SOLUTION;ORAL - 10MEQ/15ML Sponsor GENUS LIFESCIENCES Submission history Latest submission status date: 2020-03-05 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.